Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Maharashtra
Monsoon
Udaipur
Coronavirus Cases In India
Gyanvapi Mosque
Mohammed Zubair
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / Coronavirus vaccine: Bharat Biotech's COVAXIN gets expert panel nod
India

Coronavirus vaccine: Bharat Biotech's COVAXIN gets expert panel nod

Coronavirus vaccine: Bharat Biotech's COVAXIN gets expert panel nod
Written by Siddhant Pandey
Jan 03, 2021, 10:12 am 3 min read
Coronavirus vaccine: Bharat Biotech's COVAXIN gets expert panel nod

A government-appointed panel on Saturday recommended emergency-use authorization (EUA) to the COVID-19 vaccine developed by Hyderabad-based Bharat Biotech. The panel submitted its findings to the Drugs Controller General of India (DCGI), who will take a final call on the issuance of EUA. Covishield—the vaccine developed by AstraZeneca and Oxford University, and manufactured by Pune-based Serum Institute of India—has also received the panel's nod.

Panel
CDSCO panel recommends 'restricted use in emergency situation'

The Subject Expert Committee (SEC) of Central Drugs Standards Control Organisation (CDSCO) had on Saturday recommended the "grant of permission for restricted use in emergency situation in public interest as an abundant precaution, in clinical trial mode, especially in the context of infection by mutant strains, to M/s Bharat Biotech International Ltd, Hyderabad," the Union Health Ministry said.

Trial data
Recommendation comes despite lack of efficacy data

Notably, the panel's recommendation comes despite a lack of trial data indicating the vaccine's efficacy. COVAXIN has completed two out of three clinical trials so far. The third trial—which had started in November—tests for vaccine efficacy. Bharat Biotech said it has successfully recruited 23,000 out of 26,000 Phase III trial volunteers. Phase I and II trials had shown positive safety and immunogenicity results.

Information
'We have very robust Phase I and II results'

Dr. Savita Verma—a pharmacology professor from Haryana's PGIMS working on the vaccine—told NDTV, "We have very robust Phase I and II results, in which good efficacy was shown." Dr. Verma also said that around 10 million doses of COVAXIN are ready.

Covishield
Panel had recommended nod to Covishield on Friday

Earlier on Friday, the CDSCO panel had recommended Covshield for approval as well. The vaccine will "protect 95% of (its) patients," AstraZeneca CEO Pascal Soriot had said last week. Serum Institute CEO Adar Poonawalla has said that roughly 50 million doses, most of which will go to India, are already stockpiled. India will also be contributing doses to the global COVAX facility.

Information
Pfizer-BioNTech vaccine also awaiting emergency approval grant

The vaccine developed by Pfizer and BioNTech, Tozinameran or BNT162b2, is also under review by the CDSCO panel for emergency approval in India. The company is reportedly yet to present its data before the panel. The vaccine has notably been approved in several countries.

Recent news
India had held dry run for vaccine delivery yesterday

The government had on Saturday conducted a day-long trial run of the vaccine delivery system to check for potential challenges. The exercise was conducted in 116 districts and nearly one lakh personnel had undergone the necessary training, the Health Ministry said. Health Minister Dr. Harsh Vardhan said Sunday morning that there should be no misconceptions about vaccines approved in India.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Siddhant Pandey
Siddhant Pandey
Twitter
Siddhant Pandey covers national and health news at NewsBytes. He has over five years of experience working as a multimedia journalist covering hard news in New Delhi. He was previously employed with The Indian Express and News World India and has juggled roles as a correspondent, copy editor, and video producer. He holds a Bachelor’s degree in Biotechnology from the Jaypee Institute of Information Technology, Noida.
Latest
Oxford University
Union Health Ministry
Ministry of Health and Family Welfare
Central Drugs Standard Control Organization (CDSCO)
Drugs Controller General of India
Related
Latest
SL vs Australia, 2nd Test: Preview, stats, and Fantasy XI
SL vs Australia, 2nd Test: Preview, stats, and Fantasy XI Sports
Decoding the 2022 summer transfer window activities of Borussia Dortmund
Decoding the 2022 summer transfer window activities of Borussia Dortmund Sports
Manipur woman started organic food brand with just Rs. 500!
Manipur woman started organic food brand with just Rs. 500! Inspirational
Centre proposes implementation of fuel consumption standards for all vehicles
Centre proposes implementation of fuel consumption standards for all vehicles Auto
In SC petition, fact-checker Mohammed Zubair cites death threats
In SC petition, fact-checker Mohammed Zubair cites death threats India
Oxford University
COVID-19 vaccine maker Professor Sarah Gilbert honored with Barbie doll
COVID-19 vaccine maker Professor Sarah Gilbert honored with Barbie doll World
AstraZeneca vaccine's single dose reduces death risk by 80%: Data
AstraZeneca vaccine's single dose reduces death risk by 80%: Data World
#OxfordUniversity racism row: India to raise the issue when required
#OxfordUniversity racism row: India to raise the issue when required India
Five killed in Serum Institute fire; Maharashtra government orders probe
Five killed in Serum Institute fire; Maharashtra government orders probe India
Maldives to become first foreign country to receive Covishield doses
Maldives to become first foreign country to receive Covishield doses World
More News
Union Health Ministry
COVID-19: India logs 16,103 fresh cases, 31 more fatalities
COVID-19: India logs 16,103 fresh cases, 31 more fatalities India
COVID-19: India logs 11,793 new cases, 27 more deaths
COVID-19: India logs 11,793 new cases, 27 more deaths India
COVID-19: India reports 17,073 new cases; 21 more deaths
COVID-19: India reports 17,073 new cases; 21 more deaths India
COVID-19: India logs 17,336 new cases, highest in 4 months
COVID-19: India logs 17,336 new cases, highest in 4 months India
COVID-19: India logs 9,923 fresh cases, 17 more fatalities
COVID-19: India logs 9,923 fresh cases, 17 more fatalities India
More News
Ministry of Health and Family Welfare
Clinical trials for nasal COVID-19 vaccine complete: Bharat Biotech
Clinical trials for nasal COVID-19 vaccine complete: Bharat Biotech India
NEET-PG 2022 exam not postponed, fake notice being circulated: NBE
NEET-PG 2022 exam not postponed, fake notice being circulated: NBE India
All existing COVID-19 restrictions to be lifted from March 31
All existing COVID-19 restrictions to be lifted from March 31 India
India reports 1,761 more COVID-19 cases, 127 deaths
India reports 1,761 more COVID-19 cases, 127 deaths India
India's fertility rate drops to 2. What does it mean?
India's fertility rate drops to 2. What does it mean? India
More News
Central Drugs Standard Control Organization (CDSCO)
India: Phase-2 trials of world's first one-shot pneumococcal vaccine soon
India: Phase-2 trials of world's first one-shot pneumococcal vaccine soon India
Expert panel recommends emergency use authorization for Zydus's three-dose vaccine
Expert panel recommends emergency use authorization for Zydus's three-dose vaccine India
J&J withdraws vaccine approval request in India, CDSCO says
J&J withdraws vaccine approval request in India, CDSCO says India
Expert panel says no to Covovax's children trials in India
Expert panel says no to Covovax's children trials in India India
COVAXIN phase 2/3 trials for 2-18-year-olds recommended by expert panel
COVAXIN phase 2/3 trials for 2-18-year-olds recommended by expert panel India
More News
Drugs Controller General of India
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years India
COVAXIN likely to get approval for children above 2yrs: Report
COVAXIN likely to get approval for children above 2yrs: Report India
Biological E's Corbevax vaccine approved for children aged 12-18 years
Biological E's Corbevax vaccine approved for children aged 12-18 years India
COVAXIN, Covishield will now be available in hospitals and clinics
COVAXIN, Covishield will now be available in hospitals and clinics India
New anti-COVID drug may cost up to Rs. 3,000: Report
New anti-COVID drug may cost up to Rs. 3,000: Report India
More News
Related
COVAXIN supply to be increased as teens get COVID-19 vaccines
COVAXIN supply to be increased as teens get COVID-19 vaccines India
COVAXIN trial data for children aged 2-18 submitted to DCGI
COVAXIN trial data for children aged 2-18 submitted to DCGI India
India's drug regulator approves study on mixing Covishield, COVAXIN jabs
India's drug regulator approves study on mixing Covishield, COVAXIN jabs India
Government expert panel recommends conducting trials on mixing Covishield, COVAXIN
Government expert panel recommends conducting trials on mixing Covishield, COVAXIN India
Next News Article
Next News Article

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022